Localized Increases in Corticotropin-releasing Factor Receptors in Pulp after Dental Injury

Journal of Endodontics

Volumn 33, Issue 11, 2007, Pages 1319-1324

  Rutz, J Carson ^a,b   Hatton, John F ^a,b   Hildebolt, Charles ^a,c   Wells, Jason E ^a,b   Rowland, Kevin C ^a,b  

^a SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD45; CRF; CRF receptor; immunocytochemistry; pain; pulp

Indexed keywords

BETA ENDORPHIN; CD45 ANTIGEN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ANIMAL; ARTICLE; ENDODONTICS; FLUORESCENT ANTIBODY TECHNIQUE; INJURY; MALE; METABOLISM; NERVE ENDING; RAT; SPRAGUE DAWLEY RAT; TOOTH PULP;

ANIMALS; ANTIGENS, CD45; BETA-ENDORPHIN; CORTICOTROPIN-RELEASING HORMONE; DENTAL PULP; DENTAL PULP EXPOSURE; FLUORESCENT ANTIBODY TECHNIQUE; MALE; NERVE ENDINGS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 35349002717     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joen.2007.08.009     Document Type: Article

References (35)

1. Spiess J., Rivier J., Rivier C., and Vale W. Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci U S A 78 (1981) 6517-6521
2. Vale W., Spiess J., and Rivier C. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and betaendorphin. Science 213 (1981) 1394-1397
3. Rivier C., Brownstein M., Spiess J., and Vale W. In vivo corticotropin-releasing factorinduced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology 110 (1982) 272-278
4. Hargreaves K.M., Flores C.M., Dionne R.A., and Mueller G.P. The role of pituitary betaendorphin in mediating corticotropin-releasing factor-induced antinociception. Am J Physiol 258 Pt 1 (1990) E235-E242
5. Hargreaves K.M., Costello A.H., and Joris J.L. Release from inflamed tissue of a substance with properties similar to corticotropin-releasing factor. Neuroendocrinology 49 (1989) 476-482
6. Smith E.M., Morrill A.C., Meyer III W.J., and Blalock J.E. Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 321 (1986) 881-882
7. Cabot P.J., Carter L., Gaiddon C., et al. Immune cell-derived beta-endorphin: roduction, release, and control of inflammatory pain in rats. J Clin Invest 100 (1997) 142-148
8. Stein C., Hassan A.H., Przewlocki R., et al. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci U S A 87 (1990) 5935-5939
9. Hargreaves K.M., Dubner R., and Costello A.H. Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. Eur J Pharmacol 170 (1989) 275-279
10. Schafer M., Carter L., and Stein C. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci U S A 91 (1994) 4219-4223
11. Mousa S.A., Bopaiah C.P., Stein C., and Schafer M. Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain. Pain 106 (2003) 297-307
12. Hillhouse E.W., and Grammatopoulos D.K. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 27 (2006) 260-286
13. Potter E., Sutton S., Donaldson C., et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A 91 (1994) 8777-8781
14. De Souza E.B. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20 (1995) 789-819
15. Baigent S.M., and Lowry P.J. mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J Mol Endocrinol 25 (2000) 43-52
16. Rodd H.D., and Boissonade F.M. Immunocytochemical investigation of immune cells within human primary and permanent tooth pulp. Int J Paediatr Dent 16 (2006) 2-9
17. Streuli M., Morimoto C., Schrieber M., Schlossman S.F., and Saito H. Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens. J Immunol 141 (1988) 3910-3914
18. Mudie A.S., and Holland G.R. Local opioids in the inflamed dental pulp. J Endod 32 (2006) 319-323
19. Jaber L., Swaim W.D., and Dionne R.A. Immunohistochemical localization of muopioid receptors in human dental pulp. J Endod 29 (2003) 108-110
20. Fristad I., Berggreen E., and Haug S.R. Delta (delta) opioid receptors in small and medium-sized trigeminal neurons supporting the dental pulp of rats. Arch Oral Biol 51 (2006) 273-281
21. Mousa S.A., Schafer M., Mitchell W.M., Hassan A.H., and Stein C. Local upregulation of corticotropinreleasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur J Pharmacol 311 (1996) 221-231
22. Izumi T., Kobayashi I., Okamura K., and Sakai H. Immunohistochemical study on the immunocompetent cells of the pulp in human non-carious and carious teeth. Arch Oral Biol 40 (1995) 609-614
23. Kamal A.M., Okiji T., Kawashima N., and Suda H. Defense responses of dentin/pulp complex to experimentally induced caries in rat molars: an immunohistochemical study on kinetics of pulpal Ia antigen-expressing cells and macrophages. J Endod 23 (1997) 115-120
24. Byers M.R., and Narhi M.V. Dental injury models: experimental tools for understanding neuroinflammatory interactions and polymodal nociceptor functions. Crit Rev Oral Biol Med 10 (1999) 4-39
25. Rittner H.L., Brack A., Machelska H., et al. Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95 (2001) 500-508
26. Schafer M., Mousa S.A., Zhang Q., Carter L., and Stein C. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci U S A 93 (1996) 6096-6100
27. Hargreaves K.M., Mueller G.P., Dubner R., Goldstein D., and Dionne R.A. Corticotropin-releasing factor (CRF) produces analgesia in humans and rats. Brain Res 422 (1987) 154-157
28. Dionne R.A., Lepinski A.M., Gordon S.M., et al. Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clin Pharmacol Ther 70 (2001) 66-73
29. Hassan A.H., Ableitner A., Stein C., and Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55 (1993) 185-195
30. Brack A., Rittner H.L., Machelska H., et al. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain 108 (2004) 67-75
31. Stoelting R.K., and Miller R.D. Basics of anesthesia. 4th ed. (2000), Churchill Livingstone, New York
32. Brack A., Rittner H.L., Machelska H., et al. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain 112 (2004) 229-238
33. Elsharrawy E.A., and Elbaghdady Y.M. A double-blind comparison of a supplemental interligamentary injection of fentanyl and mepivacaine with 1:200,000 epinephrine for irreversible pulpitis. J Pain Symptom Manage 33 (2007) 203-207
34. Genedani S., Bernardi M., Baldini M.G., and Bertolini A. Influence of CRF and alpha-MSH on the migration of human monocytes in vitro. Neuropeptides 23 (1992) 99-102
35. Casadevall M., Saperas E., Panes J., et al. Mechanisms underlying the anti-inflammatory actions of central corticotropin-releasing factor. Am J Physiol 276 Pt 1 (1999) G1016-G1026